Ocugen (OCGN) announces FDA has issued clinical hold on IND to evaluate the COVID-19 vaccine candidate, COVAXIN

Go back to Ocugen (OCGN) announces FDA has issued clinical hold on IND to evaluate the COVID-19 vaccine candidate, COVAXIN
(NASDAQ: OCGN) Delayed: 1.02 -0.01 (0.97%)
Previous Close $1.03    52 Week High
Open $1.04    52 Week Low
Day High $1.06    P/E N/A 
Day Low $1.01    EPS
Volume 6,470,228